P

Inventor

NASVESCHUK CHRISTOPHER G

US52 patents
⚠️ This page may combine multiple inventors who share the name “NASVESCHUK CHRISTOPHER G”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

C4 THERAPEUTICS INC

25 patents
US11185592B2Nov 30, 2021

Spirocyclic degronimers for target protein degradation

C4 THERAPEUTICS INC20 citations93
US11584748B2Feb 21, 2023

Spirocyclic compounds

C4 THERAPEUTICS INC11 citations85
US11524949B2Dec 13, 2022

Degraders and Degrons for targeted protein degradation

C4 THERAPEUTICS INC7 citations85
US11459335B2Oct 4, 2022

N/O-linked Degrons and Degronimers for protein degradation

C4 THERAPEUTICS INC8 citations85
US11691972B2Jul 4, 2023

Compounds for targeted degradation of BRD9

C4 THERAPEUTICS INC5 citations81
US12371442B2Jul 29, 2025

Isoindolinone and indazole compounds for the degradation of EGFR

C4 THERAPEUTICS INC1 citations74
US12048747B2Jul 30, 2024

Substituted piperidine Degronimers for Target Protein degradation

C4 THERAPEUTICS INC4 citations74
US11623929B2Apr 11, 2023

Spirocyclic compounds

C4 THERAPEUTICS INC7 citations74
US11992531B2May 28, 2024

C3-carbon linked glutarimide degronimers for target protein degradation

C4 THERAPEUTICS INC3 citations73
US11673902B2Jun 13, 2023

Isoindolinone and indazole compounds for the degradation of EGFR

C4 THERAPEUTICS INC3 citations72
US12157735B2Dec 3, 2024

Compounds for targeted degradation of BRD9

C4 THERAPEUTICS INC1 citations69
US12049464B2Jul 30, 2024

Compounds for targeted degradation of BRD9

C4 THERAPEUTICS INC1 citations69
US12570626B2Mar 10, 2026

Degraders and degrons for targeted protein degradation

C4 THERAPEUTICS INC0 citations62
US12486290B2Dec 2, 2025

Isoindolinone and indazole compounds for the degradation of EGFR

C4 THERAPEUTICS INC0 citations62
US12441740B2Oct 14, 2025

N/O-linked degrons and degronimers for protein degradation

C4 THERAPEUTICS INC0 citations62
US12227504B2Feb 18, 2025

Spirocyclic compounds

C4 THERAPEUTICS INC0 citations62
US12180225B2Dec 31, 2024

N/O-linked degrons and degronimers for protein degradation

C4 THERAPEUTICS INC1 citations62
US12076405B2Sep 3, 2024

Heterocyclic degronimers for target protein degradation

C4 THERAPEUTICS INC1 citations62
US12048748B2Jul 30, 2024

Spirocyclic degronimers for target protein degradation

C4 THERAPEUTICS INC1 citations62
US11753397B2Sep 12, 2023

Cereblon binders for the degradation of ikaros

C4 THERAPEUTICS INC1 citations62
US12486253B2Dec 2, 2025

Therapeutics for the degradation of mutant BRAF

C4 THERAPEUTICS INC0 citations59
US12528797B2Jan 20, 2026

Heterocyclic compounds for medical treatment

C4 THERAPEUTICS INC0 citations51
US12559492B2Feb 24, 2026

BRAF degraders

C4 THERAPEUTICS INC0 citations48
US12454521B2Oct 28, 2025

Targeted protein degradation

C4 THERAPEUTICS INC0 citations48
US12421220B2Sep 23, 2025

Bicyclic-substituted glutarimide cereblon binders

C4 THERAPEUTICS INC0 citations47

CONSTELLATION PHARMACEUTICALS INC

11 patents
US9469646B2Oct 18, 2016

Modulators of methyl modifying enzymes, compositions and uses thereof

CONSTELLATION PHARMACEUTICALS INC21 citations92
US10016405B2Jul 10, 2018

Modulators of methyl modifying enzymes, compositions and uses thereof

CONSTELLATION PHARMACEUTICALS INC3 citations84
US9745305B2Aug 29, 2017

Modulators of methyl modifying enzymes, compositions and uses thereof

CONSTELLATION PHARMACEUTICALS INC11 citations84
US9522920B2Dec 20, 2016

Bromodomain inhibitors and uses thereof

CONSTELLATION PHARMACEUTICALS INC10 citations84
US9409865B2Aug 9, 2016

Modulators of methyl modifying enzymes, compositions and uses thereof

CONSTELLATION PHARMACEUTICALS INC14 citations83
US9371331B2Jun 21, 2016

Modulators of methyl modifying enzymes, compositions and uses thereof

CONSTELLATION PHARMACEUTICALS INC8 citations83
US9206128B2Dec 8, 2015

Modulators of methyl modifying enzymes, compositions and uses thereof

CONSTELLATION PHARMACEUTICALS INC10 citations83
US9051269B2Jun 9, 2015

Modulators of methyl modifying enzymes, compositions and uses thereof

CONSTELLATION PHARMACEUTICALS INC9 citations83
US9980952B2May 29, 2018

Modulators of methyl modifying enzymes, compositions and uses thereof

CONSTELLATION PHARMACEUTICALS INC3 citations73
US9969716B2May 15, 2018

Indole derivatives as modulators of methyl modifying enzymes, compositions and uses thereof

CONSTELLATION PHARMACEUTICALS INC4 citations73
USRE47428EJun 11, 2019

Modulators of methyl modifying enzymes, compositions and uses thereof

CONSTELLATION PHARMACEUTICALS INC0 citations52

GENENTECH INC

9 patents

ALBRECHT BRIAN K

2 patents

CONSTELLATION—PHARMACEUTICALS INC

1 patent

UNIV COLORADO REGENTS

1 patent

LIU XUEDONG

1 patent

Showing the top 50 of 52 patents by PatentIndex Score.